结论：在这个关键的3期研究中，奥曲肽植入物通过6个月持续释放奥曲肽，维持血gh和igf—1水平降低，并且耐受性良好。
Conclusions: in this pivotal phase 3 study, the octreotide implant maintained reduced blood levels of GH and IGF-1 with continuous octreotide release over 6 months, which was well tolerated.
目的探讨外伤性白内障后房型人工晶状体二期植入术的临床效果。
Objective To explore the clinical effect of secondary posterior chamber IOL implantation after traumatic cataract surgery.
应用推荐